tiprankstipranks
KALA BIO (KALA)
NASDAQ:KALA
US Market
Want to see KALA full AI Analyst Report?

KALA BIO (KALA) Financial Statements

1,584 Followers

KALA BIO Financial Overview

KALA BIO's market cap is currently $106.98M. The company's EPS TTM is $-4.1654; its P/E ratio is 1.65; KALA BIO is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 3.89M$ 11.24M
Gross Profit$ 0.00$ -259.00K$ -303.00K$ 1.33M$ 7.14M
Operating Income$ -39.16M$ -40.43M$ -39.15M$ -81.36M$ -109.43M
EBITDA$ -23.39M$ -40.17M$ -38.85M$ -80.50M$ -107.17M
Net Income$ -26.98M$ -38.51M$ -42.20M$ -44.82M$ -142.60M
Balance Sheet
Cash & Short-Term Investments$ 7.56M$ 51.18M$ 50.90M$ 70.50M$ 92.14M
Total Assets$ 9.49M$ 55.48M$ 55.95M$ 86.82M$ 139.43M
Total Debt$ 0.00$ 32.25M$ 36.32M$ 42.95M$ 80.19M
Net Debt$ -7.56M$ -18.93M$ -14.57M$ -27.55M$ -11.95M
Total Liabilities$ 2.49M$ 43.15M$ 48.45M$ 67.85M$ 122.62M
Stockholders' Equity$ 7.00M$ 12.33M$ 7.50M$ 18.97M$ 16.80M
Cash Flow
Free Cash Flow$ -31.99M$ -29.59M$ -28.54M$ -79.22M$ -109.12M
Operating Cash Flow$ -31.99M$ -29.38M$ -27.93M$ -78.91M$ -108.23M
Investing Cash Flow$ -15.00K$ -208.00K$ -429.00K$ 62.72M$ 70.80M
Financing Cash Flow$ -11.62M$ 29.88M$ 8.51M$ -7.94M$ 42.55M
Currency in USD

KALA BIO Earnings and Revenue History

KALA BIO Debt to Assets

KALA BIO Cash Flow

KALA BIO Forecast EPS vs Actual EPS